RWJBarnabas Health Rutgers Cancer Institute of New Jersey
A

Lymphoma During Pregnancy

By RWJBarnabas Health Rutgers Cancer Institute of New Jersey FEATURING Andrew Evens
By RWJBarnabas Health Rutgers Cancer Institute of New Jersey FEATURING Andrew Evens
162 views
September 21, 2022
Comments 0
Login to view comments. Click here to Login

Related Videos

10:07

FDA Approval of E7777 (Denileukin Diftitox) for R/R CTCL - Summary o…

Yale Cancer Center

F. Foss

307 views
27:47

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

700 views
25:22

Treatment Updates and Management of Non-Hodgkin Lymphomas

Integrity CE

D. Wallace, M. Cortese

117 views
37:26

Cutaneous Lymphoma 101: Overview on Diagnosis, Staging and Prognosis

Basem William

280 views
29:26

Practice-Changing Updates in DLBCL and HL

Massachusetts General Hospital Cancer Center

J. Erika Haydu

324 views
40:51

2024 Updates in the Management of DLBCL, FL, and HL

UNC Lineberger Comprehensive Cancer Center

A. Beaven

61 views
17:07

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Mana…

2024 ASCO® Annual Meeting Insights Hub

M. Minnema

288 views
08:18

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

955 views
23:31

Overview of Current and Future Management of CTCL

UChicago Medicine

N. Mehta-Shah

118 views
16:27

Therapeutic Advances in T-Cell Lymphoma in 2024

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Barta

325 views
17:21

Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…

Daniel Addison

409 views
08:24

The Promise of Immunotherapies in T-Cell Lymphomas

Penn Medicine Abramson Cancer Center

C. Thomas

41 views
13:58

EHA 2024 Insights: Intrathecal Rituximab + Dex for Refractory Sanctu…

Insights from 2024 EHA Annual Meeting

M. Salamoon

129 views
05:49

ASH 2024 Insights: Real-World Outcomes With Evolving Management of C…

2024 ASH Annual Meeting Insights Hub

R. Bansal

22 views
11:35

Infectious Complications in Pts Receiving CD19 vs. BCMA Targeted CAR…

Muhammad Abid

19 views
22:38

Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do a…

Indy Hematology Review

T. Phillips

157 views
05:38

Epcoritamab in NHL - Incidence and Management of CRS

GRACE

T. Phillips

175 views
20:25

What Is the Best Timing for Bispecific Antibodies and CAR-T Therapy …

SOHO Brazil 2024

A. Zelenetz

59 views
22:06

Current Overview of Biscpecific Antibodies in Hematologic Malignanci…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

B. Uncu Ulu

55 views
08:05

ASCO® 2024 Insights: "TRANSFORM Study - 3-Year Follow-Up Comparing L…

2024 ASCO® Annual Meeting Insights Hub

M. Kamdar

88 views
AUTOPLAY